AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sirot, D.
Right arrow Articles by Bret, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sirot, D.
Right arrow Articles by Bret, L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 2001, p. 2179-2180, Vol. 45, No. 7
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.7.2179-2180.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

LETTERS TO THE EDITOR

Inhibitor-Resistant TEM-33 beta -Lactamase in a Shigella sonnei Isolate


    LETTER

It has been shown that Shigella species produce a low-level chromosomally mediated beta -lactamase which does not appreciably affect the level of resistance to beta -lactams (2, 10). High rates of resistance to ampicillin among Shigella isolates are due to the production of beta -lactamases similar to TEM-1 or OXA-1. The OXA-type beta -lactamase is more prevalent than TEM-1 in ampicillin-resistant Shigella flexneri (2, 6, 7, 8). In Shigella sonnei the most commonly produced beta -lactamase is the TEM-1 enzyme (2, 6, 7).

We describe here an S. sonnei isolate which was identified by the API ID 32E system (Bio-Merieux) and by antiserum agglutination and which was obtained in 1998 from stool samples of an 8-year-old child hospitalized at Orléans Hospital (Orléans France) for diarrheal disease that appeared after a 2-month stay in Turkey. The strain was resistant to amoxicillin and ticarcillin, either as single drugs or in combination with clavulanate and piperacillin. It was also resistant to trimethoprim-sulfamethoxazole and tetracyclines and susceptible to all cephalosporins, to nalidixic acid, and to fluoroquinolones.

The purpose of the present study was to find the molecular basis of the resistance to amoxicillin-clavulanate in the S. sonnei isolate (UCK strain). A TEM-1-hyperproducing S. sonnei strain (CFS01) and an OXA-1-producing S. flexneri strain (CFS02) were studied as comparators for MIC determinations.

The MICs of amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate (clavulanic acid at a fixed concentration of 2 µg/ml), and cephalothin were determined by dilution in Mueller-Hinton agar (Sanofi Diagnostics Pasteur, Marnes-la-Coquette, France) with an inoculum of 104 CFU per spot.

The resistance pattern of S. sonnei UCK was characterized by high MICs of amoxicillin and ticarcillin alone (>2,048 µg/ml) and combined with clavulanate (2,048 µg/ml), while MICs for the OXA-1-producing S. flexneri CFS02 were much lower (amoxicillin, 256 µg/ml; amoxicillin-clavulanate, 64 µg/ml; ticarcillin, 256 µg/ml; ticarcillin-clavulanate, 32 µg/ml). Against S. sonnei CFS01 (TEM-1 hyperproducing), clavulanate partially restored the activities of amoxicillin and ticarcillin (MICs, 64 µg/ml for both combinations).

No transconjugant was obtained by mating of S. sonnei UCK with Escherichia coli HB101 as recipient strain with ticarcillin (32 µg/ml) as selective agent. Plasmid DNA content was determined by comparison with plasmids Rsa (39 kb), TP114 (61 kb), pCFF04 (85 kb), and pCFF14 (180 kb). Strain UCK contained one large plasmid of ca. 90 kb which hybridized with the TEM probe (data not shown). Isoelectric focusing performed with polyacrylamide gels containing ampholines with a pH range of 3.5 to 10.0 showed that the beta -lactamase produced by S. sonnei UCK focused at a pI of 5.4.

The nucleotide sequence analysis obtained by direct sequencing of the PCR product revealed that the sequence of the bla gene differed from that of blaTEM-1b at two positions: a G-162right-arrowT transversion (at position 1 of the -10 consensus sequence) in the promoter region and the change A-407right-arrowC, leading to the amino acid substitution Met-69right-arrowLeu in the coding region. The latter change has already been observed in the inhibitor-resistant TEM beta -lactamase IRT-5/TEM-33 (4).

Table 1 shows the sequences of the structural genes and of the promoter regions specifying this IRT enzyme. Three different blaTEM-33 genes which had the mutation A-407right-arrowC in common were reported by Goussard and Courvalin (3): blaTEM-33a, derived from blaTEM-1b with the change T-226right-arrowC, which is under the control of the weak P3 promoter (9); blaTEM-33b, derived from blaTEM-1b, which is under the control of the strong promoters Pa an Pb; and blaTEM-33c, derived from blaTEM-2 with the change A-317right-arrowC (Lys-39right-arrowGln), with the promoter region corresponding to the strong P4 promoter with the T-32right-arrowC amd G-162right-arrowT mutations. The structural gene of IRT-5/TEM-33 produced by S. sonnei UCK is identical to blaTEM-33b. The promoter region had the change G-162right-arrowT (P4), which has been shown to be responsible for the hyperproduction of TEM-1 and which is commonly found upstream from the genes for inhibitor-resistant beta -lactamases (3). This fourth gene coding for TEM-33 was designated blaTEM-33b-like.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Substitutions in blaTEM genes and derived genes encoding the inhibitor-resistant beta -lactamase TEM-33/IRT-5

Moderate resistance to amoxicillin-clavulanate (MIC90 = 16 µg/ml) has been frequently reported in S. flexneri isolates, which often produce a relatively inhibitor-resistant OXA-type enzyme (2, 8).

The high-level resistance to amoxicillin-clavulanate (2,048 µg/ml) associated with susceptibility to cephalothin (8 µg/ml) observed in S. sonnei (UCK strain) suggested the presence of a hitherto unreported TEM-33 variant in the species. The sequence diversity observed for the IRT-3/TEM-33 genes lends weight to the idea that there is a great variety of TEM genes in nature, as previously suggested by Goussard and Courvalin (3) and as recently reported by Leflon-Guibout et al. (5). In this study, the patient had received no antibiotics before the resistant strain was isolated.


    ACKNOWLEDGMENTS

We thank Rolande Perroux, Marlène Jan, and Dominique Rubio for technical assistance.

This work was supported in part by a grant from Ministère de l'Education Nationale, de la Recherche et de la Technologie.


    FOOTNOTES

* *Phone: 33 4 73 60 80 18

Fax: 33 4 73 27 74 94

E-mail: danielle.sirot{at}u-clermont1.fr


    REFERENCES

1. Ambler, R. P., A. F. W. Coulson, J. M. Frère, J. M. Ghuysen, B. Joris, M. Forsman, R. C. Lévesque, G. Tiraby, and S. G. Waley. 1991. A standard numbering scheme for the class A beta -lactamases. Biochem. J. 276:269-272.
2. Cavallo, J. D., R. Bercion, J. M. Baudet, T. Samson, M. France, and M. Meyran. 1993. Antibiotic sensitivity of 140 strains of Shigella isolated in Djibouti. Bull. Soc. Pathol. Exot. 86:35-40[Medline].
3. Goussard, S., and P. Courvalin. 1999. Updated sequence information for TEM beta -lactamase genes. Antimicrob. Agents Chemother. 43:367-370[Abstract/Free Full Text].
4. Henquell, C., C. Chanal, D. Sirot, R. Labia, and J. Sirot. 1995. Molecular characterization of nine different types of mutants among 107 inhibitor-resistant TEM beta -lactamases from clinical isolates of Escherichia coli. Antimicrob. Agents Chemother. 39:427-430[Abstract/Free Full Text].
5. Leflon-Guibout, V., V. Speldooren, B. Heym, and M.-H. Nicolas-Chanoine. 2000. Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of blaTEM genes. Antimicrob. Agents Chemother. 44:2709-2714[Abstract/Free Full Text].
6. Navia, M. M., L. Capitano, J. Ruiz, M. Vargas, H. Urassa, D. Schellemberg, J. Gascon, and J. Villa. 1999. Typing and characterization of mechanisms of resistance of Shigella spp. isolated from feces of children under 5 years of age from Ifakara, Tanzania. J. Clin. Microbiol. 37:3113-3117[Abstract/Free Full Text].
7. Schumacher, H., M. Nir, B. Mansa, and A. Grassy. 1992. beta -Lactamases in Shigella. APMIS 100:954-956[Medline].
8. Siu, L. K., J. Y. C. Lo, K. Y. Yuen, P. Y. Chau, M. H. Ng, and P. L. Ho. 2000. beta -Lactamases in Shigella flexneri isolates from Hong Kong and Shanghai and a novel OXA-1-like beta -lactamase, OXA-30. Antimicrob. Agents Chemother. 44:2034-2038[Abstract/Free Full Text].
9. Speldooren, V., B. Heym, R. Labia, and H.-H. Nicolas-Chanoine. 1998. Discriminatory detection of inhibitor-resistant beta -lactamases in Escherichia coli by single-strand conformation polymorphism-PCR. Antimicrob. Agents Chemother. 42:879-884[Abstract/Free Full Text].
10. Sutcliffe, G. 1978. Nucleotide sequence of the ampicillin resistance gene of Escherichia coli plasmid pBR322. Proc. Natl. Acad. Sci. USA 75:3727-3741[Abstract/Free Full Text].
D. Sirot*
C. Chanal
R. Bonnet
C. De Champs
J. Sirot
Faculté de Médecine
Service de Bactériologie
28 Place Henri-Dunant
63001 Clermont-Ferrand, France
L. Bret
Laboratoire de Microbiologie
Centre Hospitalier Régional d'Orléans
45032 Orléans, France


Antimicrobial Agents and Chemotherapy, July 2001, p. 2179-2180, Vol. 45, No. 7
0066-4804/01/$04.00+0   DOI: 10.1128/AAC.45.7.2179-2180.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sirot, D.
Right arrow Articles by Bret, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sirot, D.
Right arrow Articles by Bret, L.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS